Cargando…

The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy

BACKGROUND: There is a limited literature describing the oral microbiome and its diagnostic potential in paediatric inflammatory bowel disease [IBD]. METHODS: We examined the dorsum tongue microbiome by V1–V2 sequencing in a cohort of 156 treatment-naïve children diagnosed with IBD compared to 102 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmaghrawy, Khalid, Fleming, Paddy, Fitzgerald, Kirsten, Cooper, Sarah, Dominik, Anna, Hussey, Séamus, Moran, Gary P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115232/
https://www.ncbi.nlm.nih.gov/pubmed/36239621
http://dx.doi.org/10.1093/ecco-jcc/jjac155
_version_ 1785028164988174336
author Elmaghrawy, Khalid
Fleming, Paddy
Fitzgerald, Kirsten
Cooper, Sarah
Dominik, Anna
Hussey, Séamus
Moran, Gary P
author_facet Elmaghrawy, Khalid
Fleming, Paddy
Fitzgerald, Kirsten
Cooper, Sarah
Dominik, Anna
Hussey, Séamus
Moran, Gary P
author_sort Elmaghrawy, Khalid
collection PubMed
description BACKGROUND: There is a limited literature describing the oral microbiome and its diagnostic potential in paediatric inflammatory bowel disease [IBD]. METHODS: We examined the dorsum tongue microbiome by V1–V2 sequencing in a cohort of 156 treatment-naïve children diagnosed with IBD compared to 102 healthy control children. Microbiome changes over time following treatment were examined in a subset of patients and associations between IBD diagnosis and dysbiosis were explored. RESULTS: Analysis of community structure of the microbiome in tongue samples revealed that IBD samples diverged significantly from healthy control samples [PERMANOVA p = 0.0009] and exhibited a reduced abundance of Clostridia in addition to several major oral genera [Veillonella, Prevotella and Fusobacterium species] with an increased abundance of streptococci. This dysbiosis was more marked in patients with severe disease. Higher levels of the potential pathobionts Klebsiella and Pseudomonas spp. were also associated with IBD. In terms of predicted functions, the IBD oral microbiome was potentially more acidogenic and exhibited reduced capacity for B vitamin biosynthesis. We used a machine learning approach to develop a predictive model of IBD which exhibited a mean-prediction AUC [area under the ROC curve] of 0.762. Finally, we examined a subset of 53 patients following 12 months of therapy and could show resolution of oral dysbiosis as demonstrated by a shift towards a healthy community structure and a significant reduction in oral dysbiosis. CONCLUSION: Oral dysbiosis found in children with IBD is related to disease severity and resolves over time following successful IBD treatment.
format Online
Article
Text
id pubmed-10115232
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101152322023-04-20 The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy Elmaghrawy, Khalid Fleming, Paddy Fitzgerald, Kirsten Cooper, Sarah Dominik, Anna Hussey, Séamus Moran, Gary P J Crohns Colitis Original Articles BACKGROUND: There is a limited literature describing the oral microbiome and its diagnostic potential in paediatric inflammatory bowel disease [IBD]. METHODS: We examined the dorsum tongue microbiome by V1–V2 sequencing in a cohort of 156 treatment-naïve children diagnosed with IBD compared to 102 healthy control children. Microbiome changes over time following treatment were examined in a subset of patients and associations between IBD diagnosis and dysbiosis were explored. RESULTS: Analysis of community structure of the microbiome in tongue samples revealed that IBD samples diverged significantly from healthy control samples [PERMANOVA p = 0.0009] and exhibited a reduced abundance of Clostridia in addition to several major oral genera [Veillonella, Prevotella and Fusobacterium species] with an increased abundance of streptococci. This dysbiosis was more marked in patients with severe disease. Higher levels of the potential pathobionts Klebsiella and Pseudomonas spp. were also associated with IBD. In terms of predicted functions, the IBD oral microbiome was potentially more acidogenic and exhibited reduced capacity for B vitamin biosynthesis. We used a machine learning approach to develop a predictive model of IBD which exhibited a mean-prediction AUC [area under the ROC curve] of 0.762. Finally, we examined a subset of 53 patients following 12 months of therapy and could show resolution of oral dysbiosis as demonstrated by a shift towards a healthy community structure and a significant reduction in oral dysbiosis. CONCLUSION: Oral dysbiosis found in children with IBD is related to disease severity and resolves over time following successful IBD treatment. Oxford University Press 2022-10-14 /pmc/articles/PMC10115232/ /pubmed/36239621 http://dx.doi.org/10.1093/ecco-jcc/jjac155 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Elmaghrawy, Khalid
Fleming, Paddy
Fitzgerald, Kirsten
Cooper, Sarah
Dominik, Anna
Hussey, Séamus
Moran, Gary P
The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title_full The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title_fullStr The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title_full_unstemmed The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title_short The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
title_sort oral microbiome in treatment-naïve paediatric ibd patients exhibits dysbiosis related to disease severity that resolves following therapy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115232/
https://www.ncbi.nlm.nih.gov/pubmed/36239621
http://dx.doi.org/10.1093/ecco-jcc/jjac155
work_keys_str_mv AT elmaghrawykhalid theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT flemingpaddy theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT fitzgeraldkirsten theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT coopersarah theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT dominikanna theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT husseyseamus theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT morangaryp theoralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT elmaghrawykhalid oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT flemingpaddy oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT fitzgeraldkirsten oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT coopersarah oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT dominikanna oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT husseyseamus oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy
AT morangaryp oralmicrobiomeintreatmentnaivepaediatricibdpatientsexhibitsdysbiosisrelatedtodiseaseseveritythatresolvesfollowingtherapy